Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29629324
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Immunohistochemical Analysis of the Role Connective Tissue Growth Factor in
Drug-induced Gingival Overgrowth in Response to Phenytoin, Cyclosporine, and
Nifedipine
#MMPMID29629324
Anand AJ
; Gopalakrishnan S
; Karthikeyan R
; Mishra D
; Mohapatra S
J Int Soc Prev Community Dent
2018[Jan]; 8
(1
): 12-20
PMID29629324
show ga
OBJECTIVE: To evaluate for the presence of connective tissue growth factor (CTGF)
in drug (phenytoin, cyclosporine, and nifedipine)-induced gingival overgrowth
(DIGO) and to compare it with healthy controls in the absence of overgrowth.
MATERIALS AND METHODS: Thirty-five patients were chosen for the study and
segregated into study (25) and control groups (10). The study group consisted of
phenytoin-induced (10), cyclosporine-induced (10), and nifedipine-induced (5)
gingival overgrowth. After completing necessary medical evaluations, biopsy was
done. The tissue samples were fixed in 10% formalin and then
immunohistochemically evaluated for the presence of CTGF. The statistical
analysis of the values was done using statistical package SPSS PC+ (Statistical
Package for the Social Sciences, version 4.01). RESULTS: The outcome of
immunohistochemistry shows that DIGO samples express more CTGF than control group
and phenytoin expresses more CTGF followed by nifedipine and cyclosporine.
CONCLUSION: The study shows that there is an increase in the levels of CTGF in
patients with DIGO in comparison to the control group without any gingival
overgrowth. In the study, we compared the levels of CTGF in DIGO induced by three
most commonly used drugs phenytoin, cyclosporine, and nifedipine. By comparing
the levels of CTGF, we find that cyclosporine induces the production of least
amount of CTGF. Therefore, it might be a more viable drug choice with reduced
side effects.